WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Soto, Judge and Stanton give Yankees first teammates trio of season with double
Rural Tourism Route Injects New Momentum into Countryside in SW China's Chongqing
10th National Constitution Day Marked in China
Protection, Inheritance of Cultural Heritage to Be Enhanced
Hamas says to reconsider negotiating strategy
Opera Based on Story of Huang Wenxiu Performed in Guiyang
University Opens Course to Improve Parenting Skills
Xi leaves for state visits to France, Serbia, Hungary
Team Penske in spotlight as it prepares run for Indy 500 pole with Larson a serious contender
Opera Based on Story of Huang Wenxiu Performed in Guiyang